These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Laser removal of tattoos. Kuperman-Beade M; Levine VJ; Ashinoff R Am J Clin Dermatol; 2001; 2(1):21-5. PubMed ID: 11702617 [TBL] [Abstract][Full Text] [Related]
11. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review. Levin MK; Ng E; Bae YS; Brauer JA; Geronemus RG Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302 [TBL] [Abstract][Full Text] [Related]
12. Laser treatment of imipramine-induced hyperpigmentation. Atkin DH; Fitzpatrick RE J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):77-80. PubMed ID: 10863228 [TBL] [Abstract][Full Text] [Related]
13. Effect of quality-switched laser exposure in patients with history of edible gold consumption. AlHargan A; AlTalhab S; Ghobara Y; Alissa A; AlJasser MI Lasers Med Sci; 2019 Dec; 34(9):1813-1817. PubMed ID: 30945021 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous siderosis secondary to intramuscular iron dextran treated with 755 nm Q-switched alexandrite laser: A case report. Lloyd AA; Graves MS; Ross EV Lasers Surg Med; 2015 Jul; 47(5):386-7. PubMed ID: 25994768 [TBL] [Abstract][Full Text] [Related]
15. Low-fluence Q-switched Nd:YAG 1064-nm laser versus Q-switched Nd:YAG 532-nm laser in the treatment of hyperpigmented lips: a prospective, randomized, controlled, evaluator-blinded trial. Limpjaroenviriyakul N; Jurairattanaporn N; Kamanamool N; Rojhirunsakool S; Kanokrungsee S; Udompataikul M Lasers Med Sci; 2020 Feb; 35(1):165-171. PubMed ID: 31177406 [TBL] [Abstract][Full Text] [Related]
16. 532 nm Q-switched laser for the treatment of hyperpigmentation induced by topical tacrolimus. Deilhes F; Konstantinou MP; Lamant L; Paul C; Hautier JM; Livideanu CB J Cosmet Laser Ther; 2020 Feb; 22(2):90-92. PubMed ID: 32202170 [No Abstract] [Full Text] [Related]
17. Comparing the efficacy and safety of Q-switched and picosecond lasers in the treatment of nevus of Ota: a systematic review and meta-analysis. Williams NM; Gurnani P; Long J; Reynolds J; Pan Y; Suzuki T; Alhetheli GI; Nouri K Lasers Med Sci; 2021 Jun; 36(4):723-733. PubMed ID: 32839837 [TBL] [Abstract][Full Text] [Related]
18. Lasers for treatment of melasma and post-inflammatory hyperpigmentation. Arora P; Sarkar R; Garg VK; Arya L J Cutan Aesthet Surg; 2012 Apr; 5(2):93-103. PubMed ID: 23060704 [TBL] [Abstract][Full Text] [Related]
19. Delayed darkening of imipramine-induced hyperpigmentation after treatment with a Q-switched Nd:YAG laser followed by a Q-switched ruby laser. Izikson L; Anderson RR Dermatol Surg; 2009 Mar; 35(3):527-9. PubMed ID: 19250303 [No Abstract] [Full Text] [Related]
20. Optimizing Q-switched lasers for melasma and acquired dermal melanoses. Aurangabadkar SJ Indian J Dermatol Venereol Leprol; 2019; 85(1):10-17. PubMed ID: 30027914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]